ShareValue scores for 0NM7.LSE: Valuation 50, Quality 58, Growth 50, Health 51.
0NM7.LSELSE
Virbac SA
£3.44
(+1.78%)
0NM7.LSELSE
Virbac SA
£3.44(+1.78%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
58
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
51
Moderate
Financial Stability
Momentum
26
Bearish
Price Trend
Company Details
About
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Sector
IndustryN/A
ExchangeLSE
Market Cap$29M
P/E RatioN/A
Dividend Yield0.42%
Sector Rank#674
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026